BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37117107)

  • 1. Impact of Epithelial Histological Types, Subtypes, and Growth Patterns on Oncological Outcomes for Patients with Nonmetastatic Prostate Cancer Treated with Curative Intent: A Systematic Review.
    Marra G; van Leenders GJLH; Zattoni F; Kesch C; Rajwa P; Cornford P; van der Kwast T; van den Bergh RCN; Briers E; Van den Broeck T; De Meerleer G; De Santis M; Eberli D; Farolfi A; Gillessen S; Grivas N; Grummet JP; Henry AM; Lardas M; Lieuw M; Linares Espinós E; Mason MD; O'Hanlon S; van Oort IM; Oprea-Lager DE; Ploussard G; Rouvière O; Schoots IG; Stranne J; Tilki D; Wiegel T; Willemse PM; Mottet N; Gandaglia G;
    Eur Urol; 2023 Jul; 84(1):65-85. PubMed ID: 37117107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic Value of Biochemical Recurrence Following Treatment with Curative Intent for Prostate Cancer: A Systematic Review.
    Van den Broeck T; van den Bergh RCN; Arfi N; Gross T; Moris L; Briers E; Cumberbatch M; De Santis M; Tilki D; Fanti S; Fossati N; Gillessen S; Grummet JP; Henry AM; Lardas M; Liew M; Rouvière O; Pecanka J; Mason MD; Schoots IG; van Der Kwast TH; van Der Poel HG; Wiegel T; Willemse PM; Yuan Y; Lam TB; Cornford P; Mottet N
    Eur Urol; 2019 Jun; 75(6):967-987. PubMed ID: 30342843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Systematic Review of the Impact of Surgeon and Hospital Caseload Volume on Oncological and Nononcological Outcomes After Radical Prostatectomy for Nonmetastatic Prostate Cancer.
    Van den Broeck T; Oprea-Lager D; Moris L; Kailavasan M; Briers E; Cornford P; De Santis M; Gandaglia G; Gillessen Sommer S; Grummet JP; Grivas N; Lam TBL; Lardas M; Liew M; Mason M; O'Hanlon S; Pecanka J; Ploussard G; Rouviere O; Schoots IG; Tilki D; van den Bergh RCN; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Mottet N
    Eur Urol; 2021 Nov; 80(5):531-545. PubMed ID: 33962808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Management of Patients with Node-positive Prostate Cancer at Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review.
    Marra G; Valerio M; Heidegger I; Tsaur I; Mathieu R; Ceci F; Ploussard G; van den Bergh RCN; Kretschmer A; Thibault C; Ost P; Tilki D; Kasivisvanathan V; Moschini M; Sanchez-Salas R; Gontero P; Karnes RJ; Montorsi F; Gandaglia G;
    Eur Urol Oncol; 2020 Oct; 3(5):565-581. PubMed ID: 32933887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oncological outcomes of cribriform histology pattern in prostate cancer patients: a systematic review and meta-analysis.
    Russo GI; Soeterik T; Puche-Sanz I; Broggi G; Lo Giudice A; De Nunzio C; Lombardo R; Marra G; Gandaglia G;
    Prostate Cancer Prostatic Dis; 2023 Dec; 26(4):646-654. PubMed ID: 36216967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Oncological Outcomes and Data Quality in Studies Assessing Nerve-sparing Versus Non-Nerve-sparing Radical Prostatectomy in Nonmetastatic Prostate Cancer: A Systematic Review.
    Moris L; Gandaglia G; Vilaseca A; Van den Broeck T; Briers E; De Santis M; Gillessen S; Grivas N; O'Hanlon S; Henry A; Lam TB; Lardas M; Mason M; Oprea-Lager D; Ploussard G; Rouviere O; Schoots IG; van der Poel H; Wiegel T; Willemse PP; Yuan CY; Grummet JP; Tilki D; van den Bergh RCN; Cornford P; Mottet N
    Eur Urol Focus; 2022 May; 8(3):690-700. PubMed ID: 34147405
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases.
    Tavora F; Epstein JI
    Am J Surg Pathol; 2008 Jul; 32(7):1060-7. PubMed ID: 18496142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study.
    Leung D; Castellani D; Nicoletti R; Dilme RV; Sierra JM; Serni S; Franzese C; Chiacchio G; Galosi AB; Mazzucchelli R; Palagonia E; Dell'Oglio P; Galfano A; Bocciardi AM; Zhao X; Ng CF; Lee HY; Sakamoto S; Vasdev N; Rivas JG; Campi R; Teoh JY
    Eur Urol Oncol; 2024 Jan; ():. PubMed ID: 38185614
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Atypical cribriform lesions of the prostate: relationship to prostatic carcinoma and implication for diagnosis in prostate biopsies.
    Shah RB; Magi-Galluzzi C; Han B; Zhou M
    Am J Surg Pathol; 2010 Apr; 34(4):470-7. PubMed ID: 20182345
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benefits and Risks of Primary Treatments for High-risk Localized and Locally Advanced Prostate Cancer: An International Multidisciplinary Systematic Review.
    Moris L; Cumberbatch MG; Van den Broeck T; Gandaglia G; Fossati N; Kelly B; Pal R; Briers E; Cornford P; De Santis M; Fanti S; Gillessen S; Grummet JP; Henry AM; Lam TBL; Lardas M; Liew M; Mason MD; Omar MI; Rouvière O; Schoots IG; Tilki D; van den Bergh RCN; van Der Kwast TH; van Der Poel HG; Willemse PM; Yuan CY; Konety B; Dorff T; Jain S; Mottet N; Wiegel T
    Eur Urol; 2020 May; 77(5):614-627. PubMed ID: 32146018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prostatic Ductal Adenocarcinoma Controlled for Tumor Grade, Stage, and Margin Status Does Not Independently Influence the Likelihood of Biochemical Recurrence in Localized Prostate Cancer After Radical Prostatectomy.
    Kryvenko ON; Iakymenko OA; De Lima Guido LP; Bhattu AS; Merhe A; Mouzannar A; Briski LM; Oymagil I; Lugo I; Nemov I; Ritch CR; Kava BR; Punnen S; Jorda M; Parekh DJ; Gonzalgo ML
    Arch Pathol Lab Med; 2022 Aug; 146(8):1012-1017. PubMed ID: 34739539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of Localised Prostate Cancer in Kidney Transplant Patients: A Systematic Review from the EAU Guidelines on Renal Transplantation Panel.
    Hevia V; Boissier R; Rodríguez-Faba Ó; Fraser-Taylor C; Hassan-Zakri R; Lledo E; Regele H; Buddde K; Figueiredo A; Olsburgh J; Breda A
    Eur Urol Focus; 2018 Mar; 4(2):153-162. PubMed ID: 29921544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cribriform morphology is associated with higher risk of biochemical recurrence after radical prostatectomy in patients with Grade Group 5 prostate cancer.
    Oufattole J; Dey T; D'Amico AV; van Leenders GJLH; Acosta AM
    Histopathology; 2023 Jun; 82(7):1089-1097. PubMed ID: 36939057
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Large cribriform growth pattern identifies ISUP grade 2 prostate cancer at high risk for recurrence and metastasis.
    Hollemans E; Verhoef EI; Bangma CH; Rietbergen J; Helleman J; Roobol MJ; van Leenders GJLH
    Mod Pathol; 2019 Jan; 32(1):139-146. PubMed ID: 30349027
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small Cell-like Change in Central Zone Histology-A New Observation Mimicking Cribriform Intraductal Prostatic Adenocarcinoma.
    Kryvenko ON
    Int J Surg Pathol; 2021 Sep; 29(6):635-637. PubMed ID: 33729852
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Local and/or Metastasis-directed Therapy in Patients with Hormone-sensitive M1a Prostate Cancer-A Systematic Review.
    de Barros HA; van Beurden I; Droghetti M; Wilthagen EA; Özman O; Bergman AM; Aluwini S; van Moorselaar RJA; Donswijk ML; van Leeuwen PJ; van der Poel HG
    Eur Urol Oncol; 2023 Feb; 6(1):16-27. PubMed ID: 36372736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of adverse pathology features in grade group 2 prostatectomy specimens with syn- or metachronous metastatic disease.
    Ma C; Downes M; Jain R; Ientilucci M; Fleshner N; Perlis N; van der Kwast T
    Prostate; 2022 Feb; 82(3):345-351. PubMed ID: 34878188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-grade prostatic intraepithelial neoplasia, PIN-like carcinoma, ductal carcinoma, and intraductal carcinoma of the prostate.
    Zhou M
    Mod Pathol; 2018 Jan; 31(S1):S71-79. PubMed ID: 29297491
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Cribriform Pattern and Intraductal Carcinoma on Gleason 7 Prostate Cancer Treated with External Beam Radiotherapy.
    Tom MC; Nguyen JK; Lucianò R; Mian OY; Stephans KL; Ciezki JP; Smile TD; Wei W; McKenney JK; Magi-Galluzzi C; Tendulkar RD
    J Urol; 2019 Oct; 202(4):710-716. PubMed ID: 31059665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The visibility of prostate cancer concerning underlying histopathological variances: A single-center multiparametric magnetic resonance imaging study.
    Arslan A; Alis D; Tuna MB; Sağlıcan Y; Kural AR; Karaarslan E
    Eur J Radiol; 2021 Aug; 141():109791. PubMed ID: 34062471
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.